Prophylaxis Versus Preemptive Therapy for Prevention of Human Cytomegalovirus Disease in Pediatric Liver Transplant Recipients

被引：0
|
作者：
Gerna, Giuseppe [1 ]
Lilleri, Daniele [1 ]
Torre, Giuliano [2 ]
机构：
[1] Policlin San Matteo, Fdn IRCSS, Serv Virol, I-27100 Pavia, Italy
[2] Osped Riuniti Bergamo, Div Pediat, I-24100 Bergamo, Italy
来源：
TRANSPLANTATION | 2009年 / 87卷 / 02期
关键词：
D O I：
10.1097/TP.0b013e3181938beb
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：306 / 307
页数：2
相关论文
共 50 条
  • [31] Preemptive Therapy vs Antiviral Prophylaxis in Cytomegalovirus-Seronegative Liver Transplant Recipients With Seropositive Donors Reply
    Singh, Nina
    Limaye, Ajit P.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2020, 324 (11): : 1108 - 1109
  • [32] Preemptive Therapy for Cytomegalovirus Disease in Allogeneic Stem Cell Transplant Recipients
    de la Cruz-Vicente, F.
    Cerezuela Martinez, P.
    Gil-Esparraga, E.
    Martin Aguilera, C.
    Aguilar Guisado, M.
    Parody Ruiz-Berdejo, R.
    Cisneros Herreros, J. M.
    Urbano-Ispizua, A.
    Espigado Tocino, I.
    TRANSPLANTATION PROCEEDINGS, 2008, 40 (09) : 3102 - 3103
  • [33] Valganciclovir is an effective prophylaxis for cytomegalovirus disease in liver transplant recipients
    Fayek, Sameh Adel
    Mantipisitkul, Wana
    Rasetto, Flavia
    Munivenkatappa, Raghava
    Barth, Rolf N.
    Philosophe, Benjamin
    HPB, 2010, 12 (10) : 657 - 663
  • [34] Post-transplant cytomegalovirus (CMV) infection: Prophylaxis versus preemptive therapy
    Mangino, M.
    Maiorano, A.
    Schena, A.
    Ditonno, P.
    Battaglia, M.
    Palazzo, S.
    Schena, F. P.
    Grandaliano, G.
    TRANSPLANT INTERNATIONAL, 2007, 20 : 246 - 246
  • [35] Effect of Preemptive Therapy vs Antiviral Prophylaxis on Cytomegalovirus Disease in Seronegative Liver Transplant Recipients With Seropositive Donors A Randomized Clinical Trial
    Singh, Nina
    Winston, Drew J.
    Razonable, Raymund R.
    Lyon, G. Marshall
    Silveira, Fernanda P.
    Wagener, Marilyn M.
    Stevens-Ayers, Terry
    Edmison, Bradley
    Boeckh, Michael
    Limaye, Ajit P.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2020, 323 (14): : 1378 - 1387
  • [36] Preemptive Therapy in the Prevention of Cytomegalovirus Disease in High- and Low-Risk Heart Transplant Recipients
    Casquero, S.
    Rangel, D.
    Lage, E.
    Sobrino, M.
    Cristobo, P.
    Cordero, E.
    Cisneros, J. M.
    TRANSPLANTATION PROCEEDINGS, 2012, 44 (07) : 2113 - 2114
  • [37] Cytomegalovirus PP65 antigenemia monitoring as a guide for preemptive therapy: A cost effective strategy for prevention of cytomegalovirus disease in adult liver transplant recipients
    Kusne, S
    Grossi, P
    Irish, W
    St George, K
    Rinaldo, C
    Rakela, J
    Fung, J
    TRANSPLANTATION, 1999, 68 (08) : 1125 - 1131
  • [38] Effectiveness of Preemptive Therapy for Cytomegalovirus Disease in Pediatric Liver Transplantation
    Nicastro, Emanuele
    Giovannozzi, Sara
    Stroppa, Paola
    Casotti, Valeria
    Callegaro, Anna Paola
    Tebaldi, Alessandra
    Farina, Claudio
    Colledan, Michele
    D'Antiga, Lorenzo
    TRANSPLANTATION, 2017, 101 (04) : 804 - 810
  • [39] Preemptive Therapy Versus Valgancyclovir Prophylaxis in Cytomegalovirus-positive Kidney Transplant Recipients Receiving Antithymocyte Globulin Induction
    Couzi, L.
    Helou, S.
    Bachelet, T.
    Martin, S.
    Moreau, K.
    Morel, D.
    Lafon, M. E.
    Garrigue, I.
    Merville, P.
    TRANSPLANTATION PROCEEDINGS, 2012, 44 (09) : 2809 - 2813
  • [40] Randomized trial of preemptive valganciclovir therapy versus valacyclovir prophylaxis for the management of cytomegalovirus infection in kidney transplant recipients.
    Reischig, Tomas
    Jindra, Pavel
    Klaboch, Jan
    Svecova, Miroslava
    Hes, Ondrej
    Treska, Vladislav
    AMERICAN JOURNAL OF TRANSPLANTATION, 2007, 7 : 506 - 506
12345